We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phase I Clinical Trial Completes Using Cell Line Expertise at Cobra Biologics

News   Apr 03, 2017 | Original story from Cobra Biologics

 
Phase I Clinical Trial Completes Using Cell Line Expertise at Cobra Biologics

Peter Coleman, CEO of Cobra Biologics

 
 
 

RELATED ARTICLES

Improving Pregnancy Predictions for Whales

News

To identify pregnant whales, researchers have relied on hormone tests of blubber collected via darts, but the results were often inconclusive. But a new hormone test could now help give a more accurate picture.

READ MORE

Powerful "Space Odyssey" Antibiotic Developed by AI

News

Using a machine-learning algorithm, MIT researchers have identified a powerful new antibiotic compound. In laboratory tests, the drug killed many of the world's most problematic disease-causing bacteria, including some strains that are resistant to all known antibiotics. It also cleared infections in two different mouse models.

READ MORE

Clinical Trial Exposes Kidney Cancer's Weakness

News

A team have discovered how an experimental drug being investigated as a treatment for clear cell renal cell carcinoma disables its molecular target.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE